Join
Live feed
·
INSIDERFilingvia Quantisnow
Xenon Pharmaceuticals Inc. logo

PRESIDENT & CEO Mortimer Ian converted options into 12,500 shares and sold $403,584 worth of shares (7,308 units at $55.23), increasing direct ownership by 35% to 19,923 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XENE· Xenon Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XENE (Xenon Pharmaceuticals Inc.) and more on Quantisnow.